Brief overview: glucagon history and physiology.


Journal

The Journal of endocrinology
ISSN: 1479-6805
Titre abrégé: J Endocrinol
Pays: England
ID NLM: 0375363

Informations de publication

Date de publication:
01 08 2023
Historique:
received: 25 08 2022
accepted: 25 05 2023
medline: 13 7 2023
pubmed: 25 5 2023
entrez: 25 5 2023
Statut: epublish

Résumé

Glucagon is a peptide hormone that is produced primarily by the alpha cells in the islet of Langerhans in the pancreas, but also in intestinal enteroendocrine cells and in some neurons. Approximately 100 years ago, several research groups discovered that pancreatic extracts would cause a brief rise in blood glucose before they observed the decrease in glucose attributed to insulin. An overall description of the regulation of glucagon secretion requires the inclusion of its sibling insulin because they both are made primarily by the islet and they both regulate each other in different ways. For example, glucagon stimulates insulin secretion, whereas insulin suppresses glucagon secretion. The mechanism of action of glucagon on insulin secretion has been identified as a trimeric guanine nucleotide-binding protein (G-protein)-mediated event. The manner in which insulin suppresses glucagon release from the alpha cell is thought to be highly dependent on the peri-portal circulation of the islet through which blood flows downstream from beta cells to alpha cells. In this scenario, it is via the circulation that insulin is thought to suppress the release of glucagon. However, high levels of glucose also have been shown to suppress glucagon secretion. Consequently, the glucose-lowering effect of insulin may be additive to the direct effects of insulin to suppress alpha cell function, so that in vivo both the discontinuation of the insulin signal and the condition of low glucose jointly are responsible for induction of glucagon secretion.

Identifiants

pubmed: 37227172
doi: 10.1530/JOE-22-0224
pii: JOE-22-0224
doi:
pii:

Substances chimiques

Glucagon 9007-92-5
Glucagon-Like Peptide 1 89750-14-1
Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Auteurs

R Paul Robertson (RP)

Nutrition Department of Internal Medicine, Division of Metabolism Endocrinology, University of Washington, Seattle, Washington, USA.

Articles similaires

Metabolic engineering of

Jae Sung Cho, Zi Wei Luo, Cheon Woo Moon et al.
1.00
Corynebacterium glutamicum Metabolic Engineering Dicarboxylic Acids Pyridines Pyrones

Glucose and glutamine drive hepatitis E virus replication.

Shaheen Khan, Suruchi Aggarwal, Pooja Bhatia et al.
1.00
Glutamine Virus Replication Hepatitis E virus Glucose Glycolysis
Humans Insulin Resistance Muscle, Skeletal Oxidative Stress Oxidation-Reduction

Classifications MeSH